GREENBROOK TMS INC (GBNH) Stock Price, Forecast & Analysis
USA - NASDAQ:GBNH - CA3937043097 - Common Stock
GBNH Key Statistics, Chart & Performance
The current stock price of GBNH is 0.121 USD. In the past month the price decreased by -59.67%. In the past year, price decreased by -92.98%.
GBNH Latest News, Press Relases and Analysis
GBNH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.53 | 100.19B | ||
| CI | THE CIGNA GROUP | 9.31 | 70.62B | ||
| LH | LABCORP HOLDINGS INC | 15.97 | 21.00B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.39 | 20.07B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.32 | 19.93B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.06B | ||
| HIMS | HIMS & HERS HEALTH INC | 71.98 | 9.27B | ||
| DVA | DAVITA INC | 13.4 | 8.84B | ||
| CHE | CHEMED CORP | 19.76 | 6.33B | ||
| RDNT | RADNET INC | 217.53 | 6.02B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.49 | 5.87B | ||
| OPCH | OPTION CARE HEALTH INC | 18.56 | 4.49B |
Related stock screener links
About GBNH
Company Profile
Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario and currently employs 629 full-time employees. The company went IPO on 2018-11-27. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in Treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.
Company Info
GREENBROOK TMS INC
890 Yonge St 7th Floor
TORONTO ONTARIO M4W 3P4 CA
CEO: Bill Leonard
Employees: 629
Phone: 14163229700
GREENBROOK TMS INC / GBNH FAQ
What does GREENBROOK TMS INC do?
Greenbrook Tms, Inc. engages in the control and operation of a network of outpatient mental health services centers that specialize in the provision of Transcranial Magnetic Stimulation (TMS) therapy and other treatment modalities for the treatment of depression and related psychiatric services. The company is headquartered in Toronto, Ontario and currently employs 629 full-time employees. The company went IPO on 2018-11-27. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. The firm operates a network of outpatient mental health service centers that specialize in Treatment across the United States. The company offers Treatment Centers in convenient locations to provide easy access to patients and clinicians. The firm owns and operates 133 Treatment Centers in the Commonwealths of Massachusetts, Virginia and Pennsylvania and the States of Maryland, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, and South Carolina.
What is the stock price of GREENBROOK TMS INC today?
The current stock price of GBNH is 0.121 USD. The price decreased by -40.69% in the last trading session.
Does GBNH stock pay dividends?
GBNH does not pay a dividend.
What is the ChartMill technical and fundamental rating of GBNH stock?
GBNH has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is GBNH stock listed?
GBNH stock is listed on the Nasdaq exchange.
What is the analyst forecast for GBNH stock?
8 analysts have analysed GBNH and the average price target is 0.66 USD. This implies a price increase of 447.93% is expected in the next year compared to the current price of 0.121.
When does GREENBROOK TMS INC (GBNH) report earnings?
GREENBROOK TMS INC (GBNH) will report earnings on 2024-04-15, after the market close.
GBNH Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to GBNH. When comparing the yearly performance of all stocks, GBNH is a bad performer in the overall market: 98.68% of all stocks are doing better.
GBNH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GBNH. Both the profitability and financial health of GBNH have multiple concerns.
GBNH Financial Highlights
Over the last trailing twelve months GBNH reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS decreased by -49.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -78.11% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GBNH Forecast & Estimates
8 analysts have analysed GBNH and the average price target is 0.66 USD. This implies a price increase of 447.93% is expected in the next year compared to the current price of 0.121.
For the next year, analysts expect an EPS growth of 58.2% and a revenue growth 6.64% for GBNH